Publications by authors named "Hassan A Murtala"

Article Synopsis
  • Severe acute symptomatic hypocalcemia is a serious health issue often presenting as painful spasms, and innovative methods like metabolomics and genetic profiling may help identify those at risk and guide treatments.
  • The study aimed to determine the prevalence of hypocalcemia in urban Kano by analyzing retrospective data from hospital patients in 2023, finding a prevalence rate of 52.2%, with females being more affected than males.
  • Results highlight the urgent need for improved understanding of hypocalcemia's genetic factors and the potential for developing targeted public health initiatives for high-risk populations.
View Article and Find Full Text PDF

Objective: Serum cortisol has long been used in the assessment of disorders of the hypothalamic-pituitary-adrenal axis. The reference interval for cortisol in both serum and saliva depends on the analytical methodology and the population studied; hence, a locally derived population-based reference interval is recommended. To our knowledge, there are no studies on reference interval determination in the study area, raising concerns about the use of reference intervals established in European and North American populations.

View Article and Find Full Text PDF

Background: Malnutrition and sickle cell anemia (SCA) result in high childhood mortality rates. Although maternal depression is an established risk factor for malnutrition in younger children, little is known about its impact on treatment response in children with malnutrition. We aimed to determine the relationship, if any, between maternal depression scores and malnutrition treatment outcomes in older children with SCA.

View Article and Find Full Text PDF

Children with sickle cell anemia (SCA) living in Nigeria are at an increased risk of malnutrition, which contributes to increased morbidity and mortality. However, evidence-based guidelines for managing malnutrition in children with SCA are lacking. To address this gap, we conducted a multicenter, randomized controlled feasibility trial to assess the feasibility and safety of treating children with SCA aged from 5 to 12 years and having uncomplicated severe acute malnutrition (body mass index z score of <-3.

View Article and Find Full Text PDF